Non Executive Chairman - James Noble
James has extensive experience in the biotech industry and is currently Chief Executive Officer of Immunocore Limited and Adaptimmune Limited, two companies involved in T cell receptor technology. He is also a Non-executive Director of Curagen Corporation, a NASDAQ listed biopharmaceutical company, GW Pharmaceuticals PLC (AIM listed), Axellis Limited, a UK biotech company, Blue Oar Plc and Evolve. He has formerly been on the boards of a number of listed companies as a non-executive director, including Powderject Pharmaceuticals PLC (listed in London), Oxford GlycoSciences PLC (London and NASDAQ listed), Finsbury Worldwide Pharmaceutical Trust PLC (London listed), Advanced Medical Solutions PLC (AIM listed) and MediGene Ag (Frankfurt listed). He has also served as a non-executive of a large number of private biotechnology companies, including companies in the UK, Germany and the USA. As an Executive, Mr Noble was formerly the CFO of British Biotech PLC, and involved in raising over £300 million and taking the company public on NASDAQ and London. Prior to that, he was a Director at Kleinwort Benson Limited after qualifying as an accountant at Price Waterhouse in 1983. He graduated from Oxford in 1980.

Chief Executive Officer - Graham Lay
Experienced within both blue chip and early stage start-up businesses, previous roles included Senior Vice President of Johnson and Johnson Medical, General Manager of Nexan Ltd (High Tech Medical Device start up) CEO of consultancy business (LCMS) providing due diligence and business assessments to Venture Capital and businesses considering investments.

Earlier roles include worldwide Vice President R&D of Johnson and Johnson Medical, responsible for development groups within both the US and Europe. This included responsibility for the development and introduction of a new range of blood pressure monitors that remain world leaders in their class today. Roles within Johnson and Johnson included European responsibility for regulatory, clinical and technical for the CRITIKON (Johnson and Johnson) Franchise.

Graham also has experience in brand management and was an integral part of new product development and sourcing both within Europe and the rest of the world. His experience includes timely project planning and completion, worldwide quality systems, and manufacturing cost optimisation activities.

Chief Finance Officer - Oliver Cooke
Oliver is a Chartered Accountant and has over 30 years of financial and business development experience gained in a range of quoted and private companies. Mr Cooke also currently holds the post of Executive Chairman of St Helens Capital Partners LLP, a corporate finance boutique and the largest PLUS Market Corporate Advisor by number of clients.

Mr Cooke's most recent public company role was as Executive Chairman of AIM-listed Multi Group Plc. When he joined the business in 2003 it was heavily loss making and had a market capitalisation of c. £2.5 million. At the time of his departure in 2007 the business has been fully restructured, had moved into a new market sector and its market capitalisation had grown to c. £18.4 million.

Non Exec Director - James Cunningham-Davis
James graduated from the University of Buckingham with a Law degree and is a Solicitor of England and Wales, an Isle of Man Registered Legal Practitioner and a Solicitor in the Republic of Ireland. James is a Fellow of the Securities Institute and a Member of the Compliance Institute. He is a founding shareholder and director of Cavendish Trust Company Limited licensed by the Isle of Man Financial Supervision Commission as a Corporate and Trust service provider. James is Company Secretary of Pulse Group PLC (admitted on PLUS markets) and he was a Director and Company Secretary of GEM Biofuels PLC pre-IPO and he retained his position as Company Secretary after working on the Company’s successful admission to AIM.

Non Exec Director - Pritesh R Desai
Pritesh graduated in economics from the University of East Anglia and is a Fellow of the Association of Chartered Certified Accountants. Pritesh is a founding shareholder and director of Cavendish Trust Company Limited licensed by the Isle of Man Financial Supervision Commission as a Corporate and Trust service provider. He is also the founder and managing director of Blue Sea International Limited, which is involved with the structuring, management and administration of collective investment schemes. Pritesh is a Non-Executive Director and Assistant Company Secretary of GEM Biofuels PLC and a Non-Executive Director of Galleon Holdings PLC.

Non Exec Director - Christina L Rawlinson
Christina is a Fellow of the Association of Chartered Certified Accountants and a member of the Compliance Institute. Christina is a senior employee with Cavendish Trust Company Limited which is licensed by the Isle of Man Financial Supervision Commission as a Corporate and Trust Service Provider. Christina was a Director of Pactolus Hungarian Property plc pre-IPO and retained her position as Director after the Company’s successful admission to AIM.